Veterinary Medicines

FELIMINTIC 80 MG/ 20 MG TABLETS FOR CATS

Not authorised
  • Praziquantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
FELIMINTIC 80 MG/ 20 MG TABLETS FOR CATS
Felimintic
Active substance:
  • Praziquantel
  • Pyrantel embonate
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    20.00
    milligram(s)
    /
    1.00
    Tablet
  • Pyrantel embonate
    230.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Domes Pharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Europeenne De Pharmacotechnie Europhartech
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402419.00.00
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0316/001

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 3/01/2025
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 3/01/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."